SHAREHOLDERS DEFICIT |
12 Months Ended |
|---|---|
Jul. 31, 2024 | |
| SHAREHOLDERS DEFICIT | |
| SHAREHOLDERS' DEFICIT | 12. SHAREHOLDERS’ DEFICIT
As of July 31, 2024 and 2023, the Company had 40,266,149 and 34,146,149 shares of common stock issued and outstanding, respectively.
As of July 31, 2024 and 2023, the Company had 826,000 and 226,000 shares of Series A Preferred Stock issued and outstanding, respectively
As of July 31, 2024 and 2023, the Company had 0 and 0 shares of Series B Preferred Stock issued and outstanding, respectively.
As of July 31, 2024 and July 31, 2023, the Company had 412 and 300 shares of Series C Preferred Stock issued and outstanding, respectively.
On November 17, 2023, the Company sold 56 shares of Series C Preferred Stock for $48,920, net of $5,080 in offering cost.
On March 13, 2024, the Company sold 56 shares of Series C Preferred Stock for $48,920, net of $5,080 in offering cost.
On February 7, 2024, the Company issued 6,120,000 shares of common stock for $266,000 cash, all of which was received during the year ended July 31, 2022 and was included in stock payable during the year ended July 31, 2023.
During the year ended July 31, 2024, the Company issued 600,000 shares of Preferred A Stock for services valued at $222,000. |